NVP-BVB808
NVP-BVB808 is a selective and ATP-competitive JAK2 inhibitor with an IC50 of 0.35 nM. NVP-BVB808 binds to JAK2’s ATP-binding site, stabilizes JAK2’s active conformation, increases JAK2 activation loop phosphorylation, and blocks downstream kinase function. NVP-BVB808 exhibits antiproliferative and pro-apoptosis effects, suppresses constitutive STAT5a phosphorylation. NVP-BVB808 can be used for the research of cancer, such as leukemia.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1180158-99-9
- Formule: C28H32F2N8O
- Masse moléculaire:534.60
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
JAK2 0.35 nM (IC50) |
STAT5 |
NVP-BVB808 (11 individual concentrations; 72 h) potently inhibits proliferation of JAK2-mutant CHRF-288-11, SET-2, and UKE-1 cells with GI50 values of 0.15 μM, 0.25 μM, and 0.22 μM respectively after 72 hours, shows weaker activity against HEL cells (GI50 = 2.13 μM), and inhibits proliferation of BCR-ABL-positive and JAK2 wild-type cell lines only at higher concentrations (GI50 = 0.73-3.20 μM)[1].
NVP-BVB808 (72 h) induces apoptosis in CHRF-288-11, SET-2, HEL, Lama-87, KU-812, BV173, K562, and KCL-22 cells, with the highest potency against CHRF-288-11 cells (IC50 = 0.3 μM) and decreasing potency across the remaining cell lines[1].
NVP-BVB808 (0-1 μM; 30 min) potently inhibits STAT5a phosphorylation in JAK2-mutant SET-2, and HEL cells at concentrations as low as 0.05 μM after 30 minutes, while showing minimal effect on BCR-ABL-positive K562 and KCL-22 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:JAK2-mutant cell lines: CHRF-288-11, SET-2, HEL; BCR-ABL-positive cell lines: K562, KCL-22
-
Concentration:0, 0.01, 0.05, 0.1, 0.5, 1 μM
-
Incubation Time:30 min
-
Result:Suppressed constitutive STAT5a phosphorylation in SET-2 cells at 0.1 μM.
Suppressed constitutive STAT5a phosphorylation in HEL cells at ~0.5 μM.
Showed only weak to no inhibition of STAT5a phosphorylation in BCR-ABL-positive K562 and KCL-22 cells at tested concentrations.
Chemical Information
-
CAS No. 1180158-99-9
-
Masse moléculaire 534.60
-
Formule C28H32F2N8O
-
SMILES
FC(C=C1N2C3=NC(NC4=CN=C(N5C[C@H](N[C@H](C5)C)C)C=C4)=NC=C3C=C2)=C(C(F)=C1)CN6CCOCC6
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
NVP-BVB808 Related Classifications
HY-182430 Related Classifications
Powered by Bioz